Jasper Therapeutics Stock Options

JSPR Stock  USD 6.01  0.31  5.44%   
Jasper Therapeutics' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 2.28 with a put-to-call open interest ratio of 0.36 over 22 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on April 17th 2025.

Open Interest Against April 17th 2025 Option Contracts

The chart above shows Jasper Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Jasper Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Jasper Therapeutics' option, there is no secondary market available for investors to trade.

In The Money vs. Out of Money Option Contracts on Jasper Therapeutics

Analyzing Jasper Therapeutics' in-the-money options over time can help investors to take a profitable long position in Jasper Therapeutics regardless of its overall volatility. This is especially true when Jasper Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Jasper Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Jasper Therapeutics' stock while costing only a fraction of its price.

Jasper Therapeutics In The Money Call Balance

When Jasper Therapeutics' strike price is surpassing the current stock price, the option contract against Jasper Therapeutics stock is said to be in the money. When it comes to buying Jasper Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Jasper Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Jasper Current Options Market Mood

Jasper Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Jasper Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Jasper Therapeutics' options investors are not very successful. Jasper Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Jasper contract

Base on the Rule 16, the options market is currently suggesting that Jasper Therapeutics will have an average daily up or down price movement of about 0.14% per day over the life of the 2025-04-17 option contract. With Jasper Therapeutics trading at USD 6.01, that is roughly USD 0.008564. If you think that the market is fully incorporating Jasper Therapeutics' daily price movement you should consider buying Jasper Therapeutics options at the current volatility level of 2.28%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Jasper Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Jasper calls. Remember, the seller must deliver Jasper Therapeutics stock to the call owner when a call is exercised.

Jasper Therapeutics Option Chain

When Jasper Therapeutics' strike price is surpassing the current stock price, the option contract against Jasper Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Jasper Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Jasper. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Jasper. It also shows strike prices and maturity days for a Jasper Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
JSPR250417C0000500035.00.0 - 3.41.75In
Call
JSPR250417C00007500697.50.4 - 0.90.61Out
Call
JSPR250417C000100006710.00.0 - 0.550.38Out
Call
JSPR250417C000125001112.50.0 - 1.00.55Out
Call
JSPR250417C00015000215.00.0 - 2.31.15Out
Call
JSPR250417C0001750010117.50.0 - 3.10.1Out
Call
JSPR250417C00020000420.00.0 - 1.29.5Out
Call
JSPR250417C00022500822.50.0 - 4.90.3Out
Call
JSPR250417C00025000525.00.0 - 4.90.2Out
Call
JSPR250417C00030000430.00.0 - 4.91.0Out
Call
JSPR250417C000350002135.00.0 - 4.90.05Out
 Put
JSPR250417P00005000145.00.2 - 2.00.9Out
 Put
JSPR250417P00007500377.51.65 - 3.51.92In
 Put
JSPR250417P000100003310.04.3 - 5.34.8In
 Put
JSPR250417P00012500212.56.6 - 8.56.24In
 Put
JSPR250417P000150001115.08.5 - 10.27.65In
 Put
JSPR250417P00017500517.510.9 - 13.610.44In
 Put
JSPR250417P00020000520.013.5 - 15.66.0In
 Put
JSPR250417P00022500022.516.7 - 18.416.7In
 Put
JSPR250417P00025000025.019.2 - 19.819.2In
 Put
JSPR250417P00030000030.023.9 - 24.523.9In
 Put
JSPR250417P00035000035.029.0 - 30.529.0In

Jasper Total Stockholder Equity

Total Stockholder Equity

94.72 Million

At this time, Jasper Therapeutics' Total Stockholder Equity is relatively stable compared to the past year.

Jasper Therapeutics Corporate Management

Luca NotoSenior OperationsProfile
Carol ZoltowskiVP QualityProfile
Jeetinder MBAChief OfficerProfile
Wendy MDSenior MedicineProfile

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.